Blog - Melanoma Network of Canada

Libtayo (cemiplimab) Receives Positive Recommendation from the pan-Canadian Oncology Drug Review Expert Review Committee for the Treatment of Metastatic Cutaneous Squamous Cell Carcinoma

January 16, 2020UncategorizedNo Comments

Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer accounting for approximately 20% of all skin…

January 2, 2020Patient StoryNo Comments

My name is Debbie and I am a retired RN/Esthetician and I will tell you my story. Twenty-five years ago…

It has been an incredibly busy fall for the team at MNC. Heading into September, we had our 8th annual…

In March 2019, I was diagnosed with melanoma. Not just melanoma, but a particularly aggressive, nasty form known as nodular…